Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan 6mg/0.5mL injection refill (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sumatriptan 20mg nasal spray (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan 5mg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan succinate 6mg injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan succinate 12mg/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan succinate 25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan 10mg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan succinate |
Is a |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan 100mg rapid relase tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan 50mg rapid release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sumatriptan 6mg/0.5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan 4mg injection solution prefilled catridge (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan 6mg injection solution prefilled cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing naproxen sodium and sumatriptan |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sumatriptan-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing naproxen and sumatriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Naproxen- and sumatriptan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sumatriptan succinate |
Is modification of (attribute) |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naproxen and sumatriptan only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only sumatriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Naproxen and sumatriptan only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only sumatriptan in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only sumatriptan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only sumatriptan in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sumatriptan 10 mg/actuation nasal spray |
Has precise active ingredient |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sumatriptan 10 mg/actuation nasal spray |
Has basis of strength substance (attribute) |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sumatriptan 20 mg/actuation nasal spray |
Has basis of strength substance (attribute) |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sumatriptan 20 mg/actuation nasal spray |
Has precise active ingredient |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has precise active ingredient |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sumatriptan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |